NASDAQ: COCP - Cocrystal Pharma, Inc.

Lønnsomhet i seks måneder: -15.91%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Cocrystal Pharma, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection.

flere detaljer
It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2011-05-19
ISIN US19188J3005
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cocrystalpharma.com
Цена ао 1.5
Prisendring per dag: +3.5% (1.43)
Prisendring per uke: -5.13% (1.56)
Prisendring per måned: -14.94% (1.74)
Prisendring over 3 måneder: -52.1% (3.09)
Prisendring over seks måneder: -15.91% (1.76)
Prisendring per år: +5.71% (1.4)
Prisendring over 3 år: +150.85% (0.59)
Prisendring over 5 år: +8.03% (1.37)
Prisendring siden begynnelsen av året: -54.46% (3.25)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.6694 10
P/E 0 0
EV/EBITDA 0.3066 10
Total: 5

Effektivitet

Navn Betydning Karakter
ROA, % -57.53 0
ROE, % -68.16 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0822 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 59900 10
Lønnsomhet Ebitda, % 780.55 10
Lønnsomhet EPS, % -89.73 0
Total: 6
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 275656 2.71
Renaissance Technologies, LLC 125128 1.23
Blackrock Inc. 74063 0.73
Geode Capital Management, LLC 60432 0.59
Morgan Stanley 59277 0.58
Susquehanna International Group, LLP 34544 0.34
State Street Corporation 24443 0.24
Northern Trust Corporation 12207 0.12
Bank of America Corporation 8979 0.09
Tower Research Capital LLC (TRC) 5844 0.06



Veileder Stillingstittel Betaling Fødselsår
Dr. Sam Lee Ph.D. Co-Founder, Co-CEO & President 559.82k 1960 (65 år)
Prof. Roger D. Kornberg Ph.D. Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board 1947 (78 år)
Mr. James J. Martin CPA, M.B.A. Co-CEO, CFO & Corporate Secretary 1967 (58 år)

Adresse: United States, Bothell. WA, 19805 North Creek Parkway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cocrystalpharma.com